4
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Clinical and Diagnostic Findings of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in the COVID-19 Era

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Growing evidence suggests an association between the infection from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and eye disorders. The aim of this review was to analyze the clinical presentation and diagnostic features of acute macular neuroretinopathy (AMN) and paracentral acute middle maculopathy (PAMM) associated with COVID-19 infection. The features are then compared with previous reports regarding these retinal disorders, to recognize possible specific characteristics and to assess the role of multimodal ophthalmic imaging. Summary: A literature search was performed by consulting PubMed, Scopus, and Embase. The following terms were searched: “(COVID-19 OR SARS-CoV-2 OR coronavirus) AND ([acute macular neuroretinopathy] OR [paracentral acute middle maculopathy]).” Inclusion criteria were as follows: (1) publication date from January 31, 2020 to January 31, 2022; (2) English language; (3) original research or case report; (4) free full-text availability.Optical coherence tomography (OCT) findings in AMN patients were hyper-reflectivity (HR) of the outer plexiform layer, of the outer nuclear layer, and ellipsoid or interdigitation zones (EZ and IZ, respectively) disruption. In most cases, the presence of HR and EZ/IZ abnormalities resulted combined. When performed, OCT angiography (OCTA) identified attenuation of signal of the deep capillary plexus (DCP). The most common OCT finding in PAMM was an alteration of the inner nuclear layer, associated with other areas of HR, while no signs of EZ/IZ disruption were detected. When performed, OCTA showed the attenuation of signal of both the DCP and the superficial capillary plexus. Key Messages: In this review, we reported a case series of AMN and PAMM in patients with a previous or concomitant infection from SARS-CoV-2. The microvascular changes in these cases are highlighted by the OCTA scans. Even if we are far from the determination of a direct link between COVID-19 and these retinal disorders, we could hypothesize that the vascular alterations associated with SARS-CoV-2 infection could be a possible risk factor for both AMN and PAMM.

          Related collections

          Author and article information

          Journal
          OPH
          Ophthalmologica
          10.1159/issn.0030-3755
          Ophthalmologica
          Ophthalmologica
          S. Karger AG
          0030-3755
          1423-0267
          2023
          November 2023
          11 August 2023
          : 246
          : 3-4
          : 181-191
          Affiliations
          [_a] aOphthalmology Unit, ASST Sette Laghi, Circolo Hospital and Macchi Foundation, Varese, Italy
          [_b] bDepartment of Biotechnologies and Life Sciences, University of Insubria, Varese, Italy
          [_c] cMilan Center for Neuroscience (NeuroMI), Milan, Italy
          [_d] dNeurology and Stroke-Unit, Hospital Ospedale del Mare, Naples, Italy
          [_e] eAnesthesia and Intensive Care Unit, Biotechnology and Life Sciences Department, University of Insubria, Varese, Italy
          [_f] fDepartment of Life Sciences and Biotechnology, School of Biology, University of Ferrara, Ferrara, Italy
          [_g] gPsychiatry Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
          [_h] hNeurology Unit, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy
          [_i] iAnesthesia and Intensive Care Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
          [_j] jClinical – Vaccines, Clover Biopharmaceuticals, Zurich, Switzerland
          [_k] kDepartment of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK
          [_l] lClinical Infection Microbiology and Neuroimmunology, Institute of Infection, Veterinary and Ecological Science, Liverpool, UK
          [_m] mThe NIHR Health Protection Research Unit for Emerging and Zoonotic Infection, Liverpool, UK
          [_n] nDepartment of Medicine and Surgery, University of Insubria, Varese, Italy
          [_o] oNuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy
          Article
          533530 PMC10614461 Ophthalmologica 2023;246:181–191
          10.1159/000533530
          PMC10614461
          37573773
          09dcb5e8-6eb1-4f4d-87cd-dc3d2222217c
          © 2023 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

          History
          : 28 November 2022
          : 03 August 2023
          Page count
          Figures: 1, Tables: 4, Pages: 11
          Funding
          No external funding to support the production of this review.
          Categories
          Review Article

          Medicine
          Retina,COVID-19,Paracentral acute middle maculopathy,Severe acute respiratory syndrome coronavirus-2,Acute macular neuroetinopathy

          Comments

          Comment on this article